HOPA has partnered with the Association of Community Cancer Centers (ACCC) and Association of VA Hematology/Oncology (AVAHO) to lead a virtual round table to provide a unique opportunity for oncology pharmacists, healthcare professionals, and stakeholders to explore the management of drug shortages and gain valuable perspectives on the specific challenges associated with the current shortage of cisplatin and carboplatin. As the demand for effective oncology treatments continues to rise, drug shortages have become a significant concern that poses numerous challenges to healthcare providers and patients alike. Oncology pharmacists play a crucial role in addressing these shortages and ensuring optimal patient care through their expertise in drug management, therapeutic alternatives, and communication with healthcare teams. This round table webinar will bring together experienced oncology pharmacists to share their insights, experiences, and practical strategies. Through interactive discussions and real-world scenarios, participants will have the opportunity to enhance their knowledge, exchange ideas, and develop actionable plans to tackle drug shortages effectively, with a particular focus on the management of cisplatin and carboplatin shortages.
MODERATOR:
Sol Atienza, Clinical Oncology Pharmacy Specialist, Advocate Aurora Health, HOPA Board Member
PANELISTS:
Mahta Mahmoudieh, Hematology/Oncology Pharmacy Clinical Specialist, Inova Health System, Association of Community Cancer Centers (ACCC) Representative
Natalie Osagie, Clinical Pharmacy Specialist Hematology/Oncology, Veterans Affairs in Columbia Missouri, Association of VA Hematology/Oncology (AVAHO) Representative
Jeffrey Pilz, Assistant Director of Pharmacy- Medication Safety and Drug Policy, The Ohio State University Wexner Medical Center, HOPA Representative
Sarah Hudson-DiSalle, Pharmacy Manager, Medication Assistance Program and Reimbursement Services, The Ohio State University Wexner Medical Center, HOPA Representative
Peter Stuessy, Clinical Pharmacy Specialist, Oncology, Advocate Health Midwest, HOPA Representative
Sarah Hayward, Clinical Pharmacy Specialist, Stephenson Cancer Center, University of Oklahoma, HOPA Representative
